In view of the aforementioned evidences, we hypothesized that CM produces its protective effects in the HFD-C-induced NAFLD through modifying the PPAR expression and/or actions in the metabolically active tissues associated with the energy balance and fat metabolism. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.